HIV-ASSOCIATED LIPODYSTROPHY TREATMENT MARKET ANALYSIS

Increasing prevalence of HIV is expected to drive growth of the HIV-associated lipodystrophy treatment market

According to an article published in Journal of AIDS & Clinical Research in 2014, prevalence of lipodystrophy in patients suffering from HIV varies significantly and was estimated between 32.4% and 88.6%. According to World Health Organization (WHO) in 2017, more than 35 million people are suffering from HIV worldwide and an estimated 1.0 million people died from HIV in 2016. Increasing prevalence of HIV is expected to drive growth of the HIV-associated lipodystrophy market as most (32.4-88.6%) of the people suffering from HIV also suffer from HIV-associated lipodystrophy.

Approval of novel drugs in key regions such as North America is expected to drive the growth of HIV-Associated Lipodystrophy Market. For instance, in 2014, Theratechnologies Inc. received approval from Health Canada for its EGRIFTA. It is a growth hormone-releasing factor (GRF) for the treatment of HIV-associated lipodystrophy. EGRIFTA had also received the U.S. Food and Drug Administration (FDA) approval in 2010. Such approval of new drugs in the key region is expected to drive growth of the HIV-associated lipodystrophy treatment market.

The global HIV-associated lipodystrophy treatment market is segmented on the basis of lipodystrophy type, therapeutic class, and distribution channel.

On the basis of lipodystrophy type, the global HIV-associated lipodystrophy treatment market is segmented into:

• Lipoatrophy
• Lipoaccumulation

On the basis of therapeutic class, the global HIV-associated lipodystrophy treatment market is segmented into:

• Anabolism modulators
• Growth hormones
• Anabolic steroids
• Insulin resistance modulators
• Metformins
• Thiazolidinediones
• Others
• Mitochondrial antioxidants (l-carnitine)
• Other miscellaneous metabolic agents

On the basis of the distribution channel, the global HIV-associated lipodystrophy treatment market is segmented into:

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Market- Trends